Atlas Trials

A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity

Clinical trial NCT06046443 · COMPLETED

Trial details

NCT number
NCT06046443
Sponsor
Rhythm Pharmaceuticals, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hypothalamic Obesity
Start date
2024-07-11
Primary completion
2026-02-09
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.